R. Vranckx

1.4k total citations
56 papers, 838 citations indexed

About

R. Vranckx is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, R. Vranckx has authored 56 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 36 papers in Hepatology and 12 papers in Infectious Diseases. Recurrent topics in R. Vranckx's work include Hepatitis B Virus Studies (33 papers), Hepatitis C virus research (26 papers) and Hepatitis Viruses Studies and Epidemiology (21 papers). R. Vranckx is often cited by papers focused on Hepatitis B Virus Studies (33 papers), Hepatitis C virus research (26 papers) and Hepatitis Viruses Studies and Epidemiology (21 papers). R. Vranckx collaborates with scholars based in Belgium, Uganda and Indonesia. R. Vranckx's co-authors include Pierre Van Damme, A. Meheus, Guido Moens, L. Muylle, Veronik Hutse, P Jacques, A Alisjahbana, Philippe Beutels, Hans Vandenberghe and Sophie Quoilin and has published in prestigious journals such as The Lancet, The American Journal of Medicine and Vaccine.

In The Last Decade

R. Vranckx

56 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Vranckx Belgium 18 672 536 180 98 43 56 838
J.P. Chiron France 13 597 0.9× 397 0.7× 185 1.0× 114 1.2× 101 2.3× 47 774
R. Trivello Italy 20 857 1.3× 559 1.0× 228 1.3× 94 1.0× 153 3.6× 55 1.1k
Francis J. Mahoney United States 16 744 1.1× 504 0.9× 163 0.9× 207 2.1× 53 1.2× 22 976
Jeff Connell Ireland 20 790 1.2× 277 0.5× 434 2.4× 116 1.2× 70 1.6× 67 1.1k
S Thoelen Belgium 10 506 0.8× 467 0.9× 251 1.4× 85 0.9× 185 4.3× 18 816
Keith R. Perry United Kingdom 17 341 0.5× 221 0.4× 313 1.7× 44 0.4× 45 1.0× 26 684
Harrison C. Stetler United States 15 383 0.6× 119 0.2× 349 1.9× 180 1.8× 55 1.3× 23 709
K. R. Berquist United States 15 728 1.1× 504 0.9× 195 1.1× 42 0.4× 79 1.8× 28 926
F Ambrosch Austria 16 545 0.8× 415 0.8× 261 1.4× 121 1.2× 154 3.6× 51 811
Irene L. Doto United States 15 585 0.9× 255 0.5× 363 2.0× 44 0.4× 64 1.5× 27 822

Countries citing papers authored by R. Vranckx

Since Specialization
Citations

This map shows the geographic impact of R. Vranckx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Vranckx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Vranckx more than expected).

Fields of papers citing papers by R. Vranckx

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Vranckx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Vranckx. The network helps show where R. Vranckx may publish in the future.

Co-authorship network of co-authors of R. Vranckx

This figure shows the co-authorship network connecting the top 25 collaborators of R. Vranckx. A scholar is included among the top collaborators of R. Vranckx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Vranckx. R. Vranckx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giammanco, Anna, Richard Pebody, George Kafatos, et al.. (2008). European Sero-Epidemiology Network 2: Standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations. Vaccine. 26(35). 4486–4493. 17 indexed citations
2.
Gérard, Christiane, et al.. (2008). Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004–2005. Journal of Medical Virology. 80(4). 640–645. 25 indexed citations
3.
Oxford, John, Otfried Kistner, Werner Lange, et al.. (2005). A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines. Vaccine. 23(46-47). 5440–5449. 16 indexed citations
4.
Hutse, Veronik, Sophie Quoilin, Hans Vandenberghe, et al.. (2005). Oral fluid as a medium for the detection of hepatitis B surface antigen. Journal of Medical Virology. 77(1). 53–56. 29 indexed citations
5.
Vranckx, R., et al.. (2005). Hepatitis B virus (HBV) genotyping in Belgian patients with chronic HBV infection. Clinical Microbiology and Infection. 11(6). 499–501. 15 indexed citations
6.
Hutse, Veronik, et al.. (2004). Detection of HCV antibodies in oral fluid. Journal of Virological Methods. 122(2). 179–183. 36 indexed citations
7.
Hutin, Yvan, Mary Ellen Kitler, Gregory J. Dore, et al.. (2004). Global Burden of Disease (GBD) for Hepatitis C The Global Burden of Hepatitis C Working Group. 69 indexed citations
8.
Thiry, Nancy, Philippe Beutels, Ziv Shkedy, et al.. (2002). The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium). European Journal of Pediatrics. 161(11). 588–593. 43 indexed citations
9.
Moens, Guido, et al.. (2000). Prevalence of Hepatitis C Antibodies in a Large Sample of Belgian Healthcare Workers. Infection Control and Hospital Epidemiology. 21(3). 209–212. 17 indexed citations
10.
Vranckx, R., A Alisjahbana, & A. Meheus. (1999). Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates. Journal of Viral Hepatitis. 6(2). 135–139. 44 indexed citations
11.
Vranckx, R., P Jacques, & Guido Moens. (1999). Prevalence of Hepatitis A Antibodies in a Large Sample of Belgian Health Care Workers. Infection. 27(4-5). 256–258. 13 indexed citations
12.
13.
Fonck, K, et al.. (1997). Tuberculosis, HIV, hepatitis B and risk behaviour in a Belgian prison. 55. 87–97. 9 indexed citations
14.
Matheï, Catharina, Pierre Van Damme, Peggy Bruynseels, et al.. (1997). Diphtheria immunity in flanders. European Journal of Clinical Microbiology & Infectious Diseases. 16(9). 631–636. 19 indexed citations
15.
Jacques, P, Guido Moens, Pierre Van Damme, et al.. (1994). Increased risk for hepatitis A among female day nursery workers in Belgium. Occupational Medicine. 44(5). 259–261. 14 indexed citations
16.
Vranckx, R., et al.. (1994). Anti-HBs kinetics after HBV vaccination in neonates. Clinical and Diagnostic Virology. 2(6). 343–348. 2 indexed citations
17.
Vranckx, R., et al.. (1990). A Seroepidemiological Survey of HTLV-I/HTLV-II in Selected Belgian Populations. AIDS Research and Human Retroviruses. 6(7). 827–830. 2 indexed citations
18.
Vranckx, R. & L. Muylle. (1990). Hepatitis A virus antibodies in Belgium: Relationship between prevalence and age. Infection. 18(6). 364–366. 23 indexed citations
19.
Vranckx, R.. (1989). Evaluation of Different Calculation Methods for Anti-HBs Titration. Zentralblatt für Bakteriologie. 272(1). 47–57. 2 indexed citations
20.
Damme, Pierre Van, et al.. (1989). Protective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clients. The American Journal of Medicine. 87(3). S26–S29. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.P. Chiron Breakdown of academic impact, for papers by R. Trivello Breakdown of academic impact, for papers by Francis J. Mahoney Breakdown of academic impact, for papers by Jeff Connell Breakdown of academic impact, for papers by S Thoelen Breakdown of academic impact, for papers by Keith R. Perry Breakdown of academic impact, for papers by Harrison C. Stetler Breakdown of academic impact, for papers by K. R. Berquist Breakdown of academic impact, for papers by F Ambrosch Breakdown of academic impact, for papers by Irene L. Doto
Rankless by CCL
2026